Department of Surgery, Research Unit for Surgery and IBD Care, Odense University Hospital, Odense, Denmark.
University of Southern Denmark, Odense, Denmark.
BJS Open. 2021 Sep 6;5(5). doi: 10.1093/bjsopen/zrab097.
Video-assisted anal fistula treatment (VAAFT) may have a recurrence rate comparable to that of fistulectomy and sphincter repair (FSR) in the treatment of high anal fistula and with potential advantages in wound healing, functional outcome and quality of life. The aim and objectives of the study are to compare the outcome of VAAFT with that of FSR for high cryptoglandular anal fistula.
This was a single-centre randomized controlled trial of adults with high anal fistula comparing FSR with VAAFT. Primary outcome was fistula recurrence. Secondary outcomes were results of anal manometry, quality of life and faecal continence. A power calculation of 33 patients in each arm (1 : 1) was based on recurrence in the FSR and VAAFT groups of 5 per cent and 30 per cent respectively. Follow-up at 6 months after surgery included physical examination, MRI, anal manometry, quality-of-life assessment (RAND SF 36 questionnaire) and faecal-continence assessment (Wexner score).
The study was terminated early due to high recurrence rates in both groups. A total of 45 patients were included. Recurrence rates were 65 per cent for VAAFT and 27 per cent for FSR, with hazard ratio 4.18 (P = 0.016). Length of the fistula was a risk factor with an association with recurrence (hazard ratio 1.8, P = 0.020). There were significant differences in quality of life in favour of FSR and in anal manometry in favour of VAAFT with a significant improvement in Wexner score in both groups.
FSR was associated with a lower recurrence rate than VAAFT in the management of complex anal fistulae in this single-centre study but the study was terminated early due to higher than predicted recurrence rate in both groups.
NCT02585167 (http://www.clinicaltrials.org).
视频辅助肛瘘治疗(VAAFT)在治疗高位肛瘘时,其复发率可能与肛瘘切开术和括约肌修复术(FSR)相当,且在伤口愈合、功能结果和生活质量方面具有潜在优势。本研究的目的是比较 VAAFT 与 FSR 治疗高位隐窝性肛瘘的结果。
这是一项在成人高位肛瘘患者中进行的单中心随机对照试验,比较 FSR 与 VAAFT。主要结局是肛瘘复发。次要结局包括肛门测压、生活质量和粪便控制的结果。根据 FSR 组和 VAAFT 组的复发率分别为 5%和 30%,计算每组 33 例患者的效力(1:1)。术后 6 个月的随访包括体格检查、MRI、肛门测压、生活质量评估(RAND SF 36 问卷)和粪便控制评估(Wexner 评分)。
由于两组的复发率均较高,该研究提前终止。共纳入 45 例患者。VAAFT 组的复发率为 65%,FSR 组的复发率为 27%,风险比为 4.18(P=0.016)。瘘管长度是一个危险因素,与复发有关(风险比 1.8,P=0.020)。FSR 在生活质量方面明显优于 VAAFT,在肛门测压方面明显优于 VAAFT,两组的 Wexner 评分均有显著改善。
在这项单中心研究中,FSR 在治疗复杂肛瘘方面的复发率低于 VAAFT,但由于两组的复发率均高于预测,研究提前终止。
NCT02585167(http://www.clinicaltrials.org)。